Who
Thierry Chauche
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Sagimet Biosciences; Chief Financial Officer, Provention Bio.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $14K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Dec 2021
- Last trade
- 28 May 2026
- Last filed
- 1 Jun 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 1 Jun 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —88,000 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —88,000 at $0.00 | filing |
| 19 Feb 2026filed 20 Feb 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $7,0331,312 at $5.36 | filing |
| 10 Feb 2026filed 12 Feb 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $7,0321,312 at $5.36 | filing |
| 6 Feb 2025filed 7 Feb 2025 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,000 at $0.00 | filing |
| 6 Feb 2025filed 7 Feb 2025 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 6 May 2024filed 8 May 2024 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —587,181 at $0.00 | filing |
| 27 Apr 2023filed 27 Apr 2023 | Provention Biooption or derivative | SEC FORM 4 Code D | —375,000 | filing |
| 27 Apr 2023filed 27 Apr 2023 | Provention Biooption or derivative | SEC FORM 4 Code D | —50,000 | filing |
| 27 Apr 2023filed 27 Apr 2023 | Provention Biooption or derivative | SEC FORM 4 Code D | —200,000 | filing |
| 10 Jan 2023filed 11 Jan 2023 | Provention Biooption or derivative | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 18 Jan 2022filed 20 Jan 2022 | Provention Biooption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Dec 2021filed 1 Dec 2021 | Provention Biooption or derivative | SEC FORM 4 Code A | —187,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.